WNYUZ
No Result
View All Result
  • Home
  • Politics
  • Opinion
  • Business
  • World
  • Health
  • Entertainment
  • Tech
  • Home
  • Politics
  • Opinion
  • Business
  • World
  • Health
  • Entertainment
  • Tech
No Result
View All Result
WNYUZ
No Result
View All Result
Home News

Trump admin continues Biden defense of abortion drug mifepristone, asks court to dismiss lawsuit

May 6, 2025
in News
Yahoo news home
491
SHARES
1.4k
VIEWS
Share on FacebookShare on Twitter

The Trump administration is asking a federal judge in Texas to dismiss a case that aims to restrict access to the abortion drug mifepristone.

The request continues the Biden administration’s position in defense of the drug: that Texas isn’t the proper venue for the lawsuit.

In a Justice Department court filing, the Trump administration said Idaho, Missouri and Kansas have no ties to Texas, where the lawsuit was filed, arguing they lack standing in the suit against the Food and Drug Administration over its rules over the pills, which are available online and by mail.

Major Drug Stores Start Selling Abortion Pill Some Say Is ‘Dangerous’ For Women Ahead Of Landmark Scotus Case

“Aside from this litigation, the States do not dispute that their claims have no connection to the Northern District of Texas,” the DOJ wrote. “The states cannot keep alive a lawsuit in which the original plaintiffs were held to lack standing, those plaintiffs have now voluntarily dismissed their claims, and the States’ own claims have no connection to this District.”

The three Republican-led states are challenging FDA actions that loosened restrictions on the drug in 2016 and 2021, including allowing for medication abortions at up to 10 weeks of pregnancy instead of seven, and for mail delivery of the drug without a woman first seeing a clinician in-person, Reuters reported.

Read On The Fox News App

Abortion Pill Use Has Spiked In Recent Years, New Report Reveals: ‘Substantial Increase’

A lower court previously rebuffed a request to reverse FDA approval of mifepristone.

“The States are free to pursue their claims in a District where venue is proper,” the federal attorneys said. But the brief pointed to weaknesses in the states’ argument beyond standing, noting, for instance, that their challenge to the FDA’s 2016 action allowing the pills to be used up to 10 weeks of pregnancy rather than the previous seven is outside the statute of limitations.

Last year, the Supreme Court dismissed a lawsuit filed by anti-abortion doctors and medical associations after the justices ruled the plaintiffs could not show they had been personally harmed by the federal government’s regulation of the pill.

The Trump administration also argued for the dismissal, saying the states’ challenge to FDA’s 2016 actions is outside the six-year statute of limitations.

Fox News Digital’s Melissa Rudy contributed to this report. 

Original article source: Trump admin continues Biden defense of abortion drug mifepristone, asks court to dismiss lawsuit

The post Trump admin continues Biden defense of abortion drug mifepristone, asks court to dismiss lawsuit appeared first on Fox News.

Tags: drug mifepristoneFood and Drug AdministrationFox Newslawsuit filedmedication abortionsmifepristoneNorthern District of TexasThe TrumpYahooYahoo News
Share196Tweet123Share
Dutch government took control of Nexperia over fears it was being gutted
News

Dutch government took control of Nexperia over fears it was being gutted

October 28, 2025

AMSTERDAM (Reuters) -The Netherlands' decision to take control of chipmaker Nexperia in September was due to fears the company's former ...

Read more
News

Saudi AI firm Humain eyes dual listing on Saudi, NASDAQ exchanges within four years

October 28, 2025
News

Amazon says it plans to cut about 14,000 corporate jobs

October 28, 2025
News

Foxconn to invest up to $1.37 billion in AI compute cluster, supercomputing centre

October 28, 2025
News

Exclusive-Amazon targets as many as 30,000 corporate job cuts, sources say

October 27, 2025
UK faces $26.8 billion public finances gap from productivity cut, FT reports

UK faces $26.8 billion public finances gap from productivity cut, FT reports

October 27, 2025
Carbon Measures global accounting group to form independent panel

Carbon Measures global accounting group to form independent panel

October 27, 2025
Novo-backed MapLight valued at $787 million after shares jump in Nasdaq debut

Novo-backed MapLight valued at $787 million after shares jump in Nasdaq debut

October 27, 2025

© 2025 WNyuz.com

No Result
View All Result
  • Home
  • Politics
  • Opinion
  • Business
  • World
  • Health
  • Entertainment
  • Tech

© 2025 WNyuz.com